•   
  •   
  •   

US 'A game changer': FDA authorizes Abbott Labs' portable, 5-minute coronavirus test the size of a toaster

22:40  28 march  2020
22:40  28 march  2020 Source:   usatoday.com

Trump steps up effort to tout malaria drug as coronavirus 'game changer' despite doubts from FDA

  Trump steps up effort to tout malaria drug as coronavirus 'game changer' despite doubts from FDA President Trump doubled down on his campaign to cast a malaria drug as a coronavirus cure, saying the treatment could be a game changer despite skepticism from the Food and Drug Administration (FDA) and other government officials. © The Hill Trump steps up effort to tout malaria drug as coronavirus 'game changer' despite doubts from FDA "HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine. The FDA has moved mountains - Thank You!" Trump tweeted Saturday morning."Hopefully they will BOTH...be put in use IMMEDIATELY.

CHICAGO – A five-minute, point-of-care coronavirus test could be coming to urgent care clinics next week, and experts say it could be "game-changing."

The U.S. Food and Drug Administration issued Emergency Use Authorization to Illinois-based medical device maker Abbott Labs on Friday for a coronavirus test that delivers positive results in as little as five minutes and negative results in 13 minutes, the company said.

Paul defends actions before coronavirus diagnosis: 'The broader the testing and the less finger-pointing we have, the better'

  Paul defends actions before coronavirus diagnosis: 'The broader the testing and the less finger-pointing we have, the better' Sen. Rand Paul (R-Ky.), who on Sunday became the first senator diagnosed with coronavirus, is defending his actions while awaiting his test results. © Greg Nash Paul defends actions before coronavirus diagnosis: 'The broader the testing and the less finger-pointing we have, the better' "For those who want to criticize me for lack of quarantine, realize that if the rules on testing had been followed to a tee, I would never have been tested and would still be walking around the halls of the Capitol," Paul said in a statement on Monday.

Bing COVID-19 tracker: Latest numbers by country and state

The company expects the tests to be available next week and expects to ramp up manufacturing to deliver 50,000 tests per day.

Start the day smarter. Get all the news you need in your inbox each morning.

"I am pleased that the FDA authorized Abbott's point-of-care test yesterday. This is big news and will help get more of these tests out in the field rapidly," FDA Commissioner Steve Hahn said in a statement. "We know how important it is to get point-of-care tests out in the field quickly. These tests that can give results quickly can be a game changer in diagnosing COVID-19."

Get daily coronavirus updates in your inbox: Sign up for our newsletter now.

Scott Gottlieb, former FDA commissioner, echoed Hahn's comments on Twitter, calling the development a "game changer." Gottlieb also said it’s "very likely" that we’ll see additional approvals of point-of-care diagnostics behind this one, extending testing to doctor offices across the U.S.

Trump authorizes call-up of military reservists to active duty: white house

  Trump authorizes call-up of military reservists to active duty: white house U.S. President Donald Trump on Friday signed an executive order authorizing the secretaries of homeland security and defense to call up military and Coast Guard reservists to active duty, the White House said. © Reuters/JONATHAN ERNST U.S. President Trump leads daily coronavirus response briefing at the White House in Washington Under the order, the two secretaries are authorized to order reservists from the Army, Navy, Air Force and Coast Guard to active duty for up to two years "not to exceed 1,000,000 members on active duty at any one time." News to stay informed. Advice to stay safe.

The new test comes in the form of a small cartridge that fits in the palm of your hand, said John Frels, Abbott's vice president of research and development.

The test runs on the company's ID NOW platform, a 6.6-pound portable device the size of a small toaster. There are currently about 18,000 ID NOW instruments in the U.S. – the most widely available molecular point-of-care testing platform in the nation, Frels said.

News to stay informed. Advice to stay safe.
Click here for complete coronavirus coverage from Microsoft News


Unlike high-throughput batch testing platforms that can run hundreds of tests at a time but take several hours, the ID NOW platform is a bench-top instrument used at physician offices and urgent care clinics. The platform is typically used to run tests for other respiratory illnesses, such as the flu, strep and RSV – and similarly uses samples from throat and nose swabs.

Two Cubs employees reportedly test positive for COVID-19

  Two Cubs employees reportedly test positive for COVID-19 Two Cubs employees have tested positive for COVID-19, according to a report from the Chicago Sun-Times. The employees received their tests on March 23 and 24. The Cubs sent out an email to employees on Friday detailing the news. For now, publicly known details are limited.This is the first word of any known positive tests within any of the major Chicago sports teams. News to stay informed. Advice to stay safe.

8 strains of the coronavirus are circling the globe: Here's what clues they're giving scientists.

Last week, the FDA approved another coronavirus test from Abbott, the m2000 RealTime SARS CoV-2 EUA test, which is used for large batch testing at university and community hospitals. Between the two platforms, Abbott expects to produce about 5 million tests per month.

"We believe that this pandemic is going to be fought at a number of levels, starting with the diagnostic front being able to clear the backlogs in testing. That's done by making high-volume throughput tests available and at the front lines as patients present themselves at urgent care," Frels said.

Abbott did not immediately say if it planned to manufacture more ID NOW platforms, in addition to the new test cartridges. Company spokesperson Darcy Ross said the company was working with the Trump administration to determine where the tests would be sent.

COVID-19 cases in Dallas County jail reaches 17, report shows

  COVID-19 cases in Dallas County jail reaches 17, report shows An online report released Tuesday by Dallas County Health and Human Services shows the number of COVID-19 cases in jail has now reached 17. Last week, on March 25, officials confirmed five Dallas County jail inmates had tested positive for the novel coronavirus. It's unclear how the first inmate got the disease. He has been in jail since December and was held in a pod with 50 others, according to the Dallas County Sheriff's Office. In a newsLast week, on March 25, officials confirmed five Dallas County jail inmates had tested positive for the novel coronavirus.

Other companies have also received emergency use authorization from the FDA, which allows for the use of unapproved medical devices during a public health emergency.

California-based Cepheid said last week that it received authorization for a test the company says gives results within 45 minutes. Another California-based company, Mesa Biotech, said Tuesday that it received authorization for a palm-sized test that the company says gives results in 30 minutes. The test is intended for use at temporary screening facilities, physician office labs, urgent care and long term nursing facilities.

The coronavirus test that wasn't: How federal health officials misled state scientists and derailed the best chance at containment

The U.S. has struggled to ramp us testing across the nation, and, in the early days of the outbreak, the Centers for Disease Control and Prevention initially developed and mailed flawed testing kits. Many doctors have reported rationing tests to prioritize the most vulnerable.

Public health labs, as well as approved private labs, universities and hospitals, can conduct the tests. As of March 26, 92 public health laboratories in 50 states plus Washington D.C., Guam and Puerto Rico had successfully verified COVID-19 diagnostic tests and were offering testing, according to the CDC.

Opinion: Efficient, widespread testing for coronavirus could be key to holding 2020 NFL season on time

  Opinion: Efficient, widespread testing for coronavirus could be key to holding 2020 NFL season on time If the NFL season is to begin uninterrupted by the coronavirus pandemic, widespread testing will be needed to ensure safe environments.On the same day that NFL owners voted to expand the playoffs and several high-ranking league officials touted the company line of aiming for a complete season that begins on time after Labor Day, the Federal Drug Administration granted emergency use authorization for a rapid COVID-19 test that can deliver results in two minutes. The test, developed by Los Angeles-based Bodysphere, uses antibodies in blood to test for current or past infections with, according to the company, a 91% clinical specificity rate.

While there are no official nationwide testing totals, the COVID Tracking Project, an online effort started by two journalists to track the number of tests conducted in the U.S., said Friday that more than 620,000 tests had been completed nationwide – the most tests conducted by any country.

But the U.S., with a population of about 329 million, is not leading the world in the number of tests conducted per capita. South Korea, a country of about 51 million, had tested more than 370,000 people as of Friday, according to health officials. Italy, which has a population of 60 million and has reported the most coronavirus-related deaths, had tested more than 390,000 people, according to health officials.

Dr. Deborah Birx, the White House's coronavirus response coordinator, said in a Friday briefing that about 95% of testing in the U.S. is being done in commercial labs. The $2.2 trillion stimulus package approved Friday will require those labs to report total testing numbers, Birx said.

Follow Grace Hauck on Twitter @grace_hauck.

This article originally appeared on USA TODAY: 'A game changer': FDA authorizes Abbott Labs' portable, 5-minute coronavirus test the size of a toaster

Related slideshow:  Coronavirus testing ramps up

Shortage of Test Components Forces Labs to Beg, Borrow and Improvise .
As diagnostic testing continues to pick up speed in the U.S., shortages of some supplies and a backlog of samples have pushed hospitals, academic medical centers and labs to create their own patchwork solutions.Labs at places such as New York University and Stanford University are starting to make their own chemical mixtures because they can’t buy enough. A high-school lab in Tennessee managed to set up testing operations, with two science teachers leading the charge to reduce turnaround time in their area. And Northwell Health, a hospital network in New York, said it is making its own 3-D printed swabs to take samples from patients’ throats or noses.

—   Share news in the SOC. Networks

Topical videos:

usr: 1
This is interesting!